Citigroup upgraded its rating on shares of Bristol-Myers Squibb (BMY) Wednesday morning to "Buy" from "Neutral."
Bristol-Myers Squibb gapped up Wednesday and climbed for the majority of the morning. Shares ended the day higher by 2.34 at $46.40 on above average volume. The stock has been gaining ground for the last 2 weeks and set a new high for the year.
For comments and feedback: editorial@rttnews.com